Cite
HARVARD Citation
Négrier, C. et al. (2017). Postauthorization safety study of Clottafact®, a triply secured fibrinogen concentrate in acquired fibrinogen deficiency: a prospective observational study. Vox sanguinis. 113 (2), pp. 120-127. [Online].